BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  AstraZeneca PLC Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

  September 21, 2007

   · 

  5 min read
• Drug Development

  Bayer HealthCare Pharmaceuticals’s Nexavar Receives Positive Opinion from European Committee for Medicinal Products for Human Use for Treatment of Liver Cancer

  September 21, 2007

   · 

  7 min read
• Policy

  Cephalon, Inc. Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia

  September 21, 2007

   · 

  6 min read
• Pharm Country

  Alpharma Inc. to Present at 2007 UBS Warburg Global Life Sciences Conference

  September 21, 2007

   · 

  1 min read
• Pharm Country

  Gentium S.p.A. (GENT) President and Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell

  September 21, 2007

   · 

  1 min read
• FDA

  Novo Nordisk A/S’s (Jobs) Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome

  September 21, 2007

   · 

  8 min read
• Bio NC

  Laboratory Corporation of America Holdings Is Scheduled to Present at the UBS Warburg 2007 Global Life Sciences Conference

  September 21, 2007

   · 

  1 min read
• Pharm Country

  Antares Pharma, Inc. to Present at William Blair Small-Cap Growth Stock Conference

  September 21, 2007

   · 

  1 min read
• Deals

  Bausch & Lomb Shareholders Approve Merger with Affiliates of Warburg, Pincus Ventures, L.P.; $3.67 Billion Buyout

  September 21, 2007

   · 

  1 min read
• Drug Development

  Diamyd Medical AB: US National Institutes of Health (NIH) Announces Plans to Sponsor a Type 1 Diabetes Trial with the Experimental Diamyd(R) Diabetes Vaccine

  September 21, 2007

   · 

  1 min read